Serum, Bharat Biotech vaccines get restricted use approval from DCGI ...Middle East

Business Standard - News
Serum, Bharat Biotech vaccines get restricted use approval from DCGI
While the Oxford-AstraZeneca vaccine made by Serum Institute here has 70.42% efficacy, Bharat Biotech's still does not have efficacy data as trials are underway in India

Hence then, the article about serum bharat biotech vaccines get restricted use approval from dcgi was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Serum, Bharat Biotech vaccines get restricted use approval from DCGI )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News